Brief: Nabriva Therapeutics Reports Third Quarter 2020 Financial Results And Provides Corporate Updates
05/11/2020 21:28
Nov 5 (Reuters) - Nabriva Therapeutics PLC NBRV.O :
* NABRIVA THERAPEUTICS REPORTS THIRD QUARTER 2020 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATES
* Q3 REVENUE $1.3 MILLION VERSUS $6.9 MILLION
* Q3 REVENUE ESTIMATE $667,000 -- REFINITIV IBES DATA
* QTRLY LOSS PER SHARE $0.09
* Q3 EARNINGS PER SHARE VIEW $-0.10 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX1jfqvr
Further company coverage: NBRV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nabriva Therapeutics
See all newsBrief: Nabriva Therapeutics And Units Enter Asset Purchase Agreement With Sumitomo Pharma
Brief: Nabriva Therapeutics Says Received Delisting Determination Letter From Nasdaq
Brief: Nabriva Therapeutics Receives Notice Of Delisting Or Failure To Satisfy Continued Listing Rule From Nasdaq
Brief: Nabriva Therapeutics - On Jan 31, Co's Unit Entered Into Letter Agreement With 2 Units Of Merck & Co, About Distribution Agreement, Dated July 15, 2020
Brief: Nabriva Therapeutics Provides Corporate Update